Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan
SEC Form 4
Carlyle Group, a major shareholder of QuidelOrtho Corp, executed multiple sales of common stock between July 8th and July 9th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Carlyle Group, through various affiliated entities, sold shares of QuidelOrtho Corp (QDEL) common stock on July 8th and 9th, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
- On July 8th, 2024, 57,007 shares were sold at a weighted average price of $30.3458, with individual prices ranging from $30.07 to $30.9989.
- An additional 2,966 shares were sold on July 8th, 2024, at a weighted average price of $31.2852, with individual prices ranging from $31.00 to $31.55.
- On July 9th, 2024, 23,781 shares were sold at a weighted average price of $30.0706, with individual prices ranging from $30.00 to $30.33.
- Following these transactions, Carlyle Group's indirect beneficial ownership of QuidelOrtho Corp common stock stands at 11,165,970 shares.
- The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P., with various Carlyle Group entities having indirect control.
Sentiment
Score: 5
Explanation: The document itself is neutral, reporting factual transactions. The sentiment is moderately neutral as the sales are part of a pre-planned strategy, but large shareholder sales can sometimes create uncertainty.
Risks
- Continued sales by Carlyle Group could exert downward pressure on QDEL's stock price.
- The market may react negatively to the perception of a major shareholder reducing its stake.
Future Outlook
The document does not contain any specific forward-looking statements regarding QuidelOrtho's future performance or Carlyle Group's future trading activity beyond the existing 10b5-1 plan.
Industry Context
Share sales by major holders are common and can be part of portfolio management strategies. The impact on QuidelOrtho's stock will depend on market perception and overall investor sentiment towards the company and the diagnostics industry.
Stakeholder Impact
- Shareholders may react to the news of Carlyle Group selling shares.
- The sales could potentially affect the stock price of QuidelOrtho Corp.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 07/08/2024 | Date of first reported transaction (share sales) |
| 07/09/2024 | Date of second reported transaction (share sales) |
| 07/10/2024 | Date of filing of Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.